logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Nexmed (Holdings) Incorporated

USPTO Granted Patents = 29

% Expired Patents = 34.5



Forward Citations = 428

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal James L Yeager (13 out of 23 patents)

silverMedal Y Joseph Mo (9 out of 12 patents)

bronzeMedal Mingqi Lu (7 out of 7 patents)

4.  Bassam Damaj (7 out of 21 patents)

5.  Daniel W Frank (7 out of 7 patents)

6.  Servet Buyuktimkin (6 out of 20 patents)

7.  Nadir Buyuktimkin (6 out of 20 patents)

8.  Richard Martin (6 out of 54 patents)

9.  Qin Wang (4 out of 4 patents)

10.  Yiping Wang (3 out of 36 patents)

11.  Liu Liu (2 out of 159 patents)

12.  Tian Wen (2 out of 2 patents)

13.  Jieshan Bai (2 out of 2 patents)

14.  William Shifeng Wei (2 out of 2 patents)

15.  Servet Büyüktimkin (2 out of 2 patents)


Core Competencies:
Prostaglandin
Erectile Dysfunction
Raynaud's Disease
Vasospasm
Premature Ejaculation
Antimicrobial Compounds
Topical Compositions
Small Molecule Therapeutics
Electrical Stimulation
Dyclonine
Psoriasis
Antifungal

29 patents:

1. 11246932 - Prostaglandin compositions and methods for the treatment of vasospasm (2022-02-15),
2. 10632086 - Methods and compositions for treating Raynaud's disease (2020-04-28),
3. 9855231 - Methods and compositions for treating Raynaud's disease (2018-01-02),
4. 9517218 - Methods and compositions for treating raynaud's disease (2016-12-13),
5. 9220701 - Stabilized composition for treating psoriasis (2015-12-29),
6. 9066854 - Alprostadil and dyclonine for treatment of premature ejaculation (2015-06-30),
7. 9060929 - Alprostadil for treatment of premature ejaculation (2015-06-23),
8. 9056044 - Alprostadil and lidocaine treatment of premature ejaculation (2015-06-16),
9. 8962595 - Compositions of small molecule therapeutics (2015-02-24),
10. 8940794 - Methods and compositions for treating Raynaud's disease (2015-01-27),
11. 8900625 - Antimicrobial compounds and methods of use (2014-12-02),
12. 8841345 - Compositions and methods for treatment of premature ejaculation (2014-09-23),
13. 8632813 - Prostaglandin compositions and methods for the treatment of vasospasm (2014-01-21),
14. 8596859 - Device and system for mixing and dispensing components stored separately from one another (2013-12-03),
15. 8173688 - Thiazole compounds, and compositions and methods using same (2012-05-08),
Company Overview
Nexmed (Holdings) Incorporated is a biotechnology company based in San Diego, California, specializing in the development of innovative medical technologies. The organization focuses on creating advanced therapeutic solutions, particularly in the fields of dermatology and urology. With a commitment to improving patient outcomes, Nexmed leverages its proprietary drug delivery systems and formulation technologies to address unmet medical needs. The company aims to enhance the efficacy and safety of treatments through its research-driven approach.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

29 Patents

#214 in San Diego, CA

#2,768 in California

#11,631 in US

#22,570 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Nexmed (Holdings) Incorporated

Forward Citations = 428

24 inventors:

goldMedal James L Yeager (13 out of 23 patents)

silverMedal Y Joseph Mo (9 out of 12 patents)

bronzeMedal Mingqi Lu (7 out of 7 patents)

4.  Bassam Damaj (7 out of 21 patents)

5.  Daniel W Frank (7 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nexmed (Holdings) Incorporated. Retrieved from https://idiyas.com/company/nexmed-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…